{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:40:25Z","timestamp":1790700025639,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["510844896"],"award-info":[{"award-number":["510844896"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["530690968"],"award-info":[{"award-number":["530690968"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["413659045"],"award-info":[{"award-number":["413659045"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["541206655"],"award-info":[{"award-number":["541206655"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["493400536"],"award-info":[{"award-number":["493400536"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["541206600"],"award-info":[{"award-number":["541206600"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["236177352\\u2013CCR 1116"],"award-info":[{"award-number":["236177352\\u2013CCR 1116"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jtha.2024.10.025","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:15:11Z","timestamp":1731705311000},"page":"668-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration"],"prefix":"10.1016","volume":"23","author":[{"given":"Amin","family":"Polzin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6107-7421","authenticated-orcid":false,"given":"Marcel","family":"Benkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Thienel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Barcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mourikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khrystyna","family":"Shchurovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Helten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ehreiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"von Wulffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Theiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Ahlbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Zako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wildeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Al-Kassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Metzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Vornholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Pavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"L\u00fcsebrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Strecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Tiedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gliem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Zeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert B.","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Massberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.10.025_bib1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ehjcvp\/pvaa096","article-title":"The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction","volume":"7","author":"Jones","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jtha.2024.10.025_bib2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2024.10.025_bib3","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.10.025_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.10.025_bib5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.10.025_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.10.025_bib7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.10.025_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.10.025_bib9","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/cvr\/cvaa263","article-title":"Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment","volume":"117","author":"Ten Cate","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jth.13595","article-title":"Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation","volume":"15","author":"Achilles","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.025_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0040-1716750","article-title":"Noncanonical effects of oral thrombin and factor Xa inhibitors in platelet activation and arterial thrombosis","volume":"121","author":"Polzin","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.025_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.10.025_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.119.315099","article-title":"Rivaroxaban reduces arterial thrombosis by inhibition of FXa-driven platelet activation via protease activated receptor-1","volume":"126","author":"Petzold","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11239-023-02821-x","article-title":"Low dose rivaroxaban for the management of atherosclerotic cardiovascular disease","volume":"56","author":"Mazzone","year":"2023","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.10.025_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCRESAHA.120.317219","article-title":"Different DOACs control inflammation in cardiac ischemia-reperfusion differently","volume":"128","author":"Gadi","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213379","article-title":"Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - a systematic review","volume":"14","author":"Meinel","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jtha.2024.10.025_bib18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3389\/fimmu.2019.01731","article-title":"Platelets and immune responses during thromboinflammation","volume":"10","author":"Mezger","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.10.025_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fimmu.2016.00271","article-title":"Platelets: new bricks in the building of neutrophil extracellular traps","volume":"7","author":"Carestia","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.10.025_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953129","article-title":"Platelets in the NETworks interweaving inflammation and thrombosis","volume":"13","author":"Wienkamp","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.10.025_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2019.03.047","article-title":"NETosis is associated with the severity of aortic stenosis: Links with inflammation","volume":"286","author":"Kopytek","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkac044","article-title":"Neutrophil extracellular traps contribute to myofibroblast differentiation and scar hyperplasia through the toll-like receptor 9\/nuclear factor Kappa-B\/interleukin-6 pathway","volume":"10","author":"Shao","year":"2022","journal-title":"Burns Trauma"},{"key":"10.1016\/j.jtha.2024.10.025_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154225","article-title":"Neutrophil extracellular traps regulate ischemic stroke brain injury","volume":"132","author":"Denorme","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.10.025_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2018.05.015","article-title":"The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction","volume":"167","author":"Bode","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106818","article-title":"Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation","volume":"136","author":"Ding","year":"2021","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2024.10.025_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.0000151279.35780.2d","article-title":"Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction","volume":"25","author":"Busch","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.10.025_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12974-017-0926-2","article-title":"Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis","volume":"14","author":"Stolz","year":"2017","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jtha.2024.10.025_bib28","first-page":"310","article-title":"Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation","volume":"71","author":"Kondo","year":"2018","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-023-01001-5","article-title":"Rivaroxaban attenuates neutrophil maturation in the bone marrow niche","volume":"118","author":"Schneckmann","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10555-017-9682-0","article-title":"Platelet \"first responders\" in wound response, cancer, and metastasis","volume":"36","author":"Menter","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jtha.2024.10.025_bib31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/ATVBAHA.110.220467","article-title":"Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction","volume":"31","author":"Liu","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.10.025_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep38161","article-title":"Highly sensitive detection of minimal cardiac ischemia using positron emission tomography imaging of activated platelets","volume":"6","author":"Ziegler","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.10.025_bib33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00005344-199424050-00013","article-title":"Platelet-derived adenosine contributes to the cardioprotective effects of platelets against ischemia-reperfusion injury in isolated rat heart","volume":"24","author":"Yang","year":"1994","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jtha.2024.10.025_bib34","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/CIRCULATIONAHA.104.510354","article-title":"Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts","volume":"111","author":"Frangogiannis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.10.025_bib35","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI114503","article-title":"Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in\u00a0vitro","volume":"85","author":"Serhan","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.10.025_bib36","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1073\/pnas.1407123111","article-title":"Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective","volume":"111","author":"Abdulnour","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.10.025_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2024.10.025_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/08977199909002128","article-title":"Role of TGF-beta1 in platelet-mediated cardioprotection during ischemia-reperfusion in isolated rat hearts","volume":"16","author":"Mehta","year":"1999","journal-title":"Growth Factors"},{"key":"10.1016\/j.jtha.2024.10.025_bib39","article-title":"between SDF-1\/CXCR4 and SDF-1\/CXCR7 in cardiac stem cell migration","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.10.025_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.12688\/f1000research.13283.1","article-title":"The life cycle of platelet granules","volume":"7","author":"Sharda","year":"2018","journal-title":"F1000Res"},{"issue":"22","key":"10.1016\/j.jtha.2024.10.025_bib41","doi-asserted-by":"crossref","first-page":"e2346","DOI":"10.1212\/WNL.0000000000009532","article-title":"Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction","volume":"94","author":"Novotny","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2024.10.025_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2016.04.008","article-title":"Expression of pro-inflammatory genes in human endothelial cells: comparison of rivaroxaban and dabigatran","volume":"142","author":"Ellinghaus","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcvm.2020.00114","article-title":"Comparison of inflammatory mediators in patients with atrial fibrillation using warfarin or rivaroxaban","volume":"7","author":"Martins","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.10.025_bib44","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1161\/STROKEAHA.112.666818","article-title":"Secondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in mice","volume":"43","author":"Gliem","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.10.025_bib45","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V100.3.1081","article-title":"Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion","volume":"100","author":"Polg\u00e1r","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.025_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1091\/mbc.e06-09-0785","article-title":"Endobrevin\/VAMP-8 is the primary v-SNARE for the platelet release reaction","volume":"18","author":"Ren","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jtha.2024.10.025_bib47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2009-03-210211","article-title":"Endobrevin\/VAMP-8-dependent dense granule release mediates thrombus formation in\u00a0vivo","volume":"114","author":"Graham","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.025_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjcard.2021.11.021","article-title":"Meta-analysis comparing apixaban versus rivaroxaban for management of patients with nonvalvular atrial fibrillation","volume":"166","author":"Mamas","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106335","article-title":"Put out the fire: The pleiotropic anti-inflammatory action of non-vitamin K oral anticoagulants","volume":"182","author":"Russo","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib50","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtha.2024.10.025_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2016.06.008","article-title":"Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosis","volume":"144","author":"Terry","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib52","article-title":"Rivaroxaban, a direct factor Xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway","volume":"8","author":"Ichikawa","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.10.025_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacbts.2022.03.009","article-title":"S1P lyase inhibition starting after ischemia\/reperfusion improves postischemic cardiac remodeling","volume":"7","author":"Polzin","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jtha.2024.10.025_bib54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000511279","article-title":"MTX treatment does not improve outcome in mice with AMI","volume":"106","author":"Dannenberg","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.jtha.2024.10.025_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/9780470942390.mo100149","article-title":"Arterial pressure monitoring in mice","volume":"1","author":"Zhao","year":"2011","journal-title":"Curr Protoc Mouse Biol"},{"key":"10.1016\/j.jtha.2024.10.025_bib56","doi-asserted-by":"crossref","first-page":"H1086","DOI":"10.1152\/ajpheart.00811.2007","article-title":"In\u00a0vivo measurement of flow-mediated vasodilation in living rats using high-resolution ultrasound","volume":"294","author":"Heiss","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib57","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1152\/japplphysiol.01302.2012","article-title":"Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in\u00a0vivo","volume":"114","author":"Chen","year":"2013","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.jtha.2024.10.025_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.782760","article-title":"Acute heart failure after reperfused ischemic stroke: association with systemic and cardiac inflammatory responses","volume":"12","author":"Vornholz","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC Scientific Expert Panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib60","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"j Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.10.025_bib61","article-title":"A\u00a0proteomics workflow reveals predictive autoantigens in idiopathic pulmonary fibrosis","volume":"2021","author":"Leuschner","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jtha.2024.10.025_bib62","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ","volume":"13","author":"Cox","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jtha.2024.10.025_bib63","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.10.025_bib64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest--non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtha.2024.10.025_bib65","article-title":"Fitting Linear mixed-effects models using lme4","author":"Bates","year":"2014","journal-title":"J\u00a0Stat Soft"},{"key":"10.1016\/j.jtha.2024.10.025_bib66","article-title":"LmerTest: tests in linear mixed effects models","volume":"2","author":"Kuznetsova","year":"2015","journal-title":"R\u00a0Package Version"},{"key":"10.1016\/j.jtha.2024.10.025_bib67","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362400641X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362400641X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:08:47Z","timestamp":1778818127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362400641X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S153878362400641X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.025","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}